Feb 5, 2014 · Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy.

Jul 12, 2023 · In 2020, ASCO published a guideline on the management of cancer cachexia in adults with advanced cancer. 1 Evidence was insufficient to strongly endorse any pharmacologic agent, but recommendations supported clinicians in offering a short-term trial of a progesterone analog or corticosteroid to patients experiencing loss of weight and/or appetite. The Expert …

Sep 25, 2018 · Background: Current protocol for post-operative patients admitted to medical-surgical/telemetry units from post anesthesia care units states vital signs are taken every 15 minutes for 1 hour, every 30 minutes for 2 hours and then, every 4 hours for 24 hours. To date, published evidence-based research regarding the frequency and duration of vital signs to …

Jul 13, 2020 · The systematic reviews included 3 publications from the updated search and 10 publications on CPIs. Two phase III trials in adult patients with non–small-cell lung cancers evaluating a platinum-based doublet with or without the programmed death 1 (PD-1) inhibitor pembrolizumab recommended that all patients receive dexamethasone as a component of the …

To wrap up 2024, we proudly present the Top 5 articles from each JCO Journal. The editors and staff are grateful to all of our authors for choosing JCO Journals to publish their work. Meric-Bernstam et al Darolutamide in Combination With Androgen-Deprivation Therapy …

Background: Metastatic adrenocortical carcinoma (mACC) is a rare, aggressive tumour of the adrenal gland, with historically poor survival and limited established treatment modalities. The aim of this study was to systematically search for and analyse all prospective trials for mACC to establish benchmark response and survival outcomes.

Nov 12, 2024 · ASCO Living Guideline Updates TherapyforStageIVNon–SmallCellLungCancerWithDriver Alterations: ASCO Living Guideline, Version 2024.2 Lyudmila Bazhenova, MD1;Nofisat ...

JCO Precision Oncology (JCO PO) is a peer-reviewed, online-only journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Submit Subscribe For Authors

Apr 17, 2024 · A large crowd of 2023 ASCO Annual Meeting participants walk across the Sky Bridge. The 2024 ASCO Annual Meeting will be held from May 31 to June 4, at McCormick Place in Chicago, as well as online.

ASCO special articles Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline Larissa A. Korde, MD1; Mark R. Somerfield ...